291 related articles for article (PubMed ID: 27826806)
21. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
Müller H; Scott RJ
Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234
[TBL] [Abstract][Full Text] [Related]
22. Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis.
Douma KF; Aaronson NK; Vasen HF; Verhoef S; Gundy CM; Bleiker EM
Eur J Hum Genet; 2010 Feb; 18(2):186-93. PubMed ID: 19809485
[TBL] [Abstract][Full Text] [Related]
23. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
24. Strategies for clinical implementation of screening for hereditary cancer syndromes.
Heald B; Marquard J; Funchain P
Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
[TBL] [Abstract][Full Text] [Related]
25. Hereditary cancers in children and ethical and psychosocial implications.
MacDonald DJ; Lessick M
J Pediatr Nurs; 2000 Aug; 15(4):217-25. PubMed ID: 10969494
[TBL] [Abstract][Full Text] [Related]
26. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
[TBL] [Abstract][Full Text] [Related]
27. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
28. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Nguyen KA; Syed JS; Espenschied CR; LaDuca H; Bhagat AM; Suarez-Sarmiento A; O'Rourke TK; Brierley KL; Hofstatter EW; Shuch B
Cancer; 2017 Nov; 123(22):4363-4371. PubMed ID: 28787086
[TBL] [Abstract][Full Text] [Related]
29. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
[TBL] [Abstract][Full Text] [Related]
30. At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98.
Moll AC; Imhof SM; Meeteren AY; Boers M
Br J Ophthalmol; 2000 Oct; 84(10):1170-2. PubMed ID: 11004105
[TBL] [Abstract][Full Text] [Related]
31. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
[TBL] [Abstract][Full Text] [Related]
32. Hereditary cancer syndromes: a radiologist's perspective.
Shinagare AB; Giardino AA; Jagannathan JP; Van den Abbeele AD; Ramaiya NH
AJR Am J Roentgenol; 2011 Dec; 197(6):W1001-7. PubMed ID: 22109313
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
34. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
Hes FJ; van der Luijt RB
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary gastric and pancreatic cancer].
Langner C
Pathologe; 2017 May; 38(3):164-169. PubMed ID: 28484856
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing in Tunisian families with heritable retinoblastoma using a low cost approach permits accurate risk prediction in relatives and reveals incomplete penetrance in adults.
Ayari Jeridi H; Bouguila H; Ansperger-Rescher B; Baroudi O; Mdimegh I; Omran I; Charradi K; Bouzayene H; Benammar-Elgaaïed A; Lohmann DR
Exp Eye Res; 2014 Jul; 124():48-55. PubMed ID: 24810223
[TBL] [Abstract][Full Text] [Related]
37. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
Lammens CR; Aaronson NK; Wagner A; Sijmons RH; Ausems MG; Vriends AH; Ruijs MW; van Os TA; Spruijt L; Gómez García EB; Kluijt I; Nagtegaal T; Verhoef S; Bleiker EM
J Clin Oncol; 2010 Jun; 28(18):3008-14. PubMed ID: 20479422
[TBL] [Abstract][Full Text] [Related]
39. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
Kehrer-Sawatzki H; Cooper DN
J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
[TBL] [Abstract][Full Text] [Related]
40. Dominant inheritance in human cancer.
Müller H
Anticancer Res; 1990; 10(2B):505-11. PubMed ID: 2190528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
